New ParaUS FDA clearances:
BTL Emsella is intended to provide entirely non-invasive electromagnetic stimulation of pelvic floor musculature for the purpose of rehabilitation of weak pelvic muscles and restoration of neuromuscular control for the treatment of urinary incontinence in women.
Results and patient experience may vary.
As with any medical procedure, ask your doctor if the procedure is right for you.
These products, the methods of manufacture or the use may be subject to one or more U.S. or foreign patents or pending applications.
© 2018 BTL Group of Companies. All rights reserved. BTL®, EMSELLA®, and HIFEM® are registered trademarks in the United States of America, the European Union and/or other countries.